For me it is a steady news drip; Restoration of trading, restructuring update, director appointment, also website states “ ASSEMBLING A NEW PORTFOLIO OF CUTTING-EDGE COMPANIES”, just waiting on the news….
Great to see some others contributing to the industries belief in AFC’s gen sets, Southern Oil, Juelich, Altaaqa, Urban airport, DeNora, keep em coming we are on the move, upwards 👆 not long now…..
Public consultation ends tomorrow 9th but not sure what that means, however when I review the 19th May RNS it suggests next update is due in October, or have I read this wrong?
“ Since final performance data for the Genedrive® CYP2C19 ID test is not yet available; and the product has not yet been registered in the UK under UKCA marking, the NICE Committee reasonably comments that no recommendation can yet be made for clinical use. The Company is anticipating UKCA marking of the Genedrive CYP2C19 test prior to NICE's final report, currently scheduled for October. At that time, NICE will have the option to update the recommendation on the Genedrive CYP2C19-ID Kit.”
Checkout the 1 and 3 MW Micro-grid Offerings in the literature section and the piece relating to Fuel Cells, this I assume is also where AFC are involved with ABB. There is a duplicate of text in the documents, curious.